A Multicenter, Randomized, Controlled Clinical Trial of Chidamide Combined With Venetoclax and Azacitidine in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Not Suitable for Intensive Chemotherapy
Latest Information Update: 30 Sep 2024
At a glance
- Drugs Tucidinostat (Primary) ; Azacitidine; Azacitidine; Venetoclax
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
Most Recent Events
- 20 Sep 2024 Status changed from not yet recruiting to recruiting.
- 04 May 2024 New trial record